Hedeker Wealth’s Novartis NVS Stock Holding History

Hedeker Wealth’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-5,491	Closed	-$410K	–	79
2017 Q2	$410K	Hold	5,491	–	–	0.39%	71
2017 Q1	$365K	Hold	5,491	–	–	0.35%	80
2016 Q4	$358K	Buy	5,491 +72	+1%	+$4.67K	0.29%	92
2016 Q3	$453	Buy	+5,419	New	+$395K	0.02%	133
2016 Q2	–	Sell	-5,491	Closed	-$379K	–	96
2016 Q1	$356K	Hold	5,491	–	–	0.33%	66
2015 Q4	$423K	Buy	5,491 +78	+1%	+$6.2K	0.37%	60
2015 Q3	$446K	Sell	5,413 -78	-1%	-$6.94K	0.39%	63
2015 Q2	$484K	Buy	5,491 +78	+1%	+$7.16K	0.39%	59
2015 Q1	$478K	Hold	5,413	–	–	0.4%	62
2014 Q4	$449K	Buy	+5,413	New	+$449K	0.36%	68

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Hedeker Wealth's NVS Position: Q3 2017 in Review

Hedeker Wealth sold out of Novartis (NVS) in Q3 2017, closing a stake of 5,491 shares — an estimated $410K sold.

Hedeker Wealth first reported a position in NVS in Q4 2014 and held it in 10 quarters. The position peaked at $484K in Q2 2015. 937 funds tracked by Wall St. Rank hold NVS as of Q3 2017.

Hedeker Wealth reported no remaining Novartis position as of Q3 2017 after selling out during the quarter.
Hedeker Wealth sold 5,491 Novartis shares in Q3 2017, an estimated $410K.
Hedeker Wealth first reported a position in Novartis in Q4 2014 and held it in 10 quarters.
Hedeker Wealth's Novartis position peaked at $484K in Q2 2015.
937 funds tracked by Wall St. Rank held Novartis as of Q3 2017.

Based on Hedeker Wealth's 13F filing for Q3 2017, filed 13 Nov 2017.